Abstract:Abstract Background Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease, which lacks well-established diagnostic laboratory parameters that could be used to evaluate disease severity, thromboembolism or cardiovascular events and to predict clinical prognosis. Coagulation cascade and platelet functions have not been well studied in the COVID-19 patients. Methods A total of 178 patients enrolled in Wuhan Huoshenshan Hospital were included for the study. Blood platelets and coagulation functions were analyzed in COVID-19 patients with non-severe and severe subgroups. Other biochemical laboratory parameters were also analyzed. Results Forty-nine (27.5%) out of 178 patients were diagnosed with severe disease in this study, and 129 patients with non-severe disease. Severe disease group had significant lower platelet count 186.00 (103.50–249.00) ×109/L than 251.00 (202.00–317.00) ×109/L of non-severe group, p = 0.000. Severe group also had significantly abnormal coagulation parameters than non-severe group: prothrombin time (PT) 14.55 (13.40–16.53) s vs. 12.70 (12.15–13.59) s, p = 0.000; international normalized ratio (INR) 1.21 (1.13–1.36) vs. 1.06 (1.01–1.13), p = 0.000; thrombin time (TT) 16.35 (15.69–17.47) s vs. 15.68 (14.79–16.69) s, p = 0.011; D-Dimer 1.05 (0.68–5.90) mg/L vs. 0.42 (0.28–0.79) mg/L, p = 0.000; While the liver function parameter alanine aminotransferase (ALT) and aspartate aminotransferase (AST) didn’t show significance between two groups, ALT 30.80 (19.00–58.30) IU/L vs. 28.80 (15.75–50.15) IU/L, p = 0.487; AST 27.80 (19.30–40.55) IU/L vs. 22.6 (16.7–32.03) IU/L, p = 0.102. Disseminated intravascular coagulation (DIC) rate was 6.1% in severe group while 0% in non-severe group. Survival rate of severe disease group was worse than non-severe group, 85.7% vs. 100%, p = 0.000. Thrombocytopenia correlated with coagulation function, DIC rate and survival. Six out of 7 death case had thrombocytopenia during hospitalization, and platelet count decreased subsequently until death. Thrombocytopenia occurred within 1 week after admission in 6 recovered patients. And increased platelet levels followed by positive SARS-CoV-2 IgM/IgG and negative coronavirus nucleic acid tested in 8 recovered patients. Conclusions Low platelet count is associated with abnormal coagulation function and increased risk of DIC, severe disease manifestation and increased mortality in patients with COVID-19.

Dynamic changes in coagulation parameters and correlation with disease severity and mortality in patients with COVID-19

Prediction of Severe Illness Due to COVID-19 Based on an Analysis of Initial Fibrinogen to Albumin Ratio and Platelet Count.

SARS-CoV-2 Induced Thrombocytopenia As an Important Biomarker Significantly Correlated with Abnormal Coagulation Function, Increased Intravascular Blood Clot Risk and Mortality in COVID-19 Patients

Coagulation Dysfunction In Icu Patients With Coronavirus Disease 2019 In Wuhan, China: A Retrospective Observational Study Of 75 Fatal Cases

Characteristics of coagulation alteration in patients with COVID-19

Early coagulation tests predict risk stratification and prognosis of COVID-19

Coagulopathy in patients with Coronavirus Disease 2019（COVID-19）：a systemetic review and meta-analysis

Association of coagulation disturbances with severity of COVID-19: a longitudinal study

The values of coagulation function in COVID-19 patients

Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China.

Coagulopathy in patients with COVID-19: a systematic review and meta-analysis

Coagulation dysfunction is associated with severity of COVID‐19: A meta‐analysis

Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis

The effect of coagulation factors in 2019 novel coronavirus patients A systematic review and meta-analysis

Role of Coagulation Profile in Predicting Disease Severity Among Patients of COVID-19

Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis

Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19

COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU

Coagulation Profile in COVID-19 Patients and its Relation to Disease Severity and Overall Survival: A Single-Center Study

Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19

Common Coagulopathies Associated With COVID-19 Patients